[{"Assets_0_Q3_USD":"1701779000.0","CIK":"1576280","CommonStockSharesIssued_0_Q3_shares":"102413638.0","CommonStockSharesOutstanding_0_Q3_shares":"102413638.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-1.58","EarningsPerShareBasic_3_Q3_USD":"-5.04","EarningsPerShareDiluted_1_Q3_USD":"-1.58","EarningsPerShareDiluted_3_Q3_USD":"-5.04","Industry":"Medical Specialities","Market":"NASDAQ","Market Cap":"7427038249.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-218714000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-161994000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-514654000.0","OfficialName":"Guardant Health Inc. Common Stock","ProfitLoss_1_Q3_USD":"-161994000.0","ProfitLoss_3_Q3_USD":"-514654000.0","RevenuesConverted_1_Q3_USD":"117404000.0","RevenuesConverted_3_Q3_USD":"322647000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"166745000.0","Ticker":"GH","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"102289000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"102065000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"102289000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"102065000.0","filed":"20221103","footnote":"As of December 31, 2021, the Company's consolidated balance sheet included $20.4 million of assets, that can be used only to settle obligations of Guardant Health AMEA, Inc., the consolidated variable interest entity, or VIE, and VIEs subsidiaries, and $4.3 million of liabilities of the consolidated VIE and VIEs subsidiaries, for which their creditors do not have recourse to the general credit of the Company. Guardant Health AMEA, Inc. is no longer a VIE, after the completion of the Joint Venture Acquisit","form":"10-Q","fp":"Q3","fy":"2022.0","name":"GUARDANT HEALTH, INC.","period":"20220930","qtrs":"0","uom":"USD"}]